ATAI
Price
$1.28
Change
-$0.04 (-3.03%)
Updated
Apr 4, 02:29 PM (EDT)
Capitalization
260.77M
46 days until earnings call
CYBN
Price
$5.51
Change
-$0.45 (-7.55%)
Updated
Apr 4, 02:33 PM (EDT)
Capitalization
130.92M
Ad is loading...

ATAI vs CYBN

Header iconATAI vs CYBN Comparison
Open Charts ATAI vs CYBNBanner chart's image
ATAI Life Sciences
Price$1.28
Change-$0.04 (-3.03%)
Volume$100
Capitalization260.77M
Cybin
Price$5.51
Change-$0.45 (-7.55%)
Volume$300
Capitalization130.92M
ATAI vs CYBN Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. CYBN commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and CYBN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (ATAI: $1.32 vs. CYBN: $5.96)
Brand notoriety: ATAI and CYBN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 55% vs. CYBN: 66%
Market capitalization -- ATAI: $260.77M vs. CYBN: $130.92M
ATAI [@Biotechnology] is valued at $260.77M. CYBN’s [@Biotechnology] market capitalization is $130.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileCYBN’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • CYBN’s FA Score: 1 green, 4 red.
According to our system of comparison, ATAI is a better buy in the long-term than CYBN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while CYBN’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 5 bearish.
  • CYBN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CYBN is a better buy in the short-term than ATAI.

Price Growth

ATAI (@Biotechnology) experienced а -16.24% price change this week, while CYBN (@Biotechnology) price change was -15.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

ATAI is expected to report earnings on May 20, 2025.

CYBN is expected to report earnings on Nov 13, 2024.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($261M) has a higher market cap than CYBN($131M). ATAI YTD gains are higher at: -1.128 vs. CYBN (-32.426). ATAI has higher annual earnings (EBITDA): -124.33M vs. CYBN (-134.52M). CYBN has more cash in the bank: 136M vs. ATAI (85.9M). CYBN has less debt than ATAI: CYBN (0) vs ATAI (23.8M). ATAI has higher revenues than CYBN: ATAI (331K) vs CYBN (0).
ATAICYBNATAI / CYBN
Capitalization261M131M199%
EBITDA-124.33M-134.52M92%
Gain YTD-1.128-32.4263%
P/E RatioN/AN/A-
Revenue331K0-
Total Cash85.9M136M63%
Total Debt23.8M0-
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAICYBN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 19 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTSX32.27N/A
N/A
Artisan Small Cap Investor
AAAAX12.35N/A
N/A
DWS RREEF Real Assets A
SBHVX13.88N/A
N/A
Segall Bryant & Hamill Sm Cp Val Ins
AFCWX16.13N/A
N/A
American Century Focused Intl Gr R
SFPIX11.95N/A
N/A
Saratoga Financial Services I

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-11.15%
MNMD - ATAI
48%
Loosely correlated
-7.04%
CYBN - ATAI
46%
Loosely correlated
-4.79%
COUR - ATAI
45%
Loosely correlated
-6.07%
VCYT - ATAI
45%
Loosely correlated
-5.51%
RXRX - ATAI
44%
Loosely correlated
-9.07%
More

CYBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYBN has been loosely correlated with ATAI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CYBN jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYBN
1D Price
Change %
CYBN100%
-4.79%
ATAI - CYBN
45%
Loosely correlated
-11.15%
ABSI - CYBN
35%
Loosely correlated
-9.88%
ABCL - CYBN
34%
Loosely correlated
-5.86%
MNMD - CYBN
34%
Loosely correlated
-7.04%
ATOS - CYBN
30%
Poorly correlated
-6.56%
More